Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Internal Medicine

• Publication date

  2003-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-138-9-200305060-00007PMID 12729425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How we diagnose and treat deep vein thrombosis.

  2002cited by this paper
• Prospective Assessment of a Nomogram for the Initiation of Oral Anticoagulation Therapy for Outpatient Treatment of Venous Thromboembolism

  2002cited by this paper
• A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

  1999cited by this paper
• Randomized Assessment of a Warfarin Nomogram for Initial Oral Anticoagulation after Venous Thromboembolic Disease

  1998cited by this paper
• Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

  1998cited by this paper
• Warfarin: Less May Be Better

  1997cited by this paper
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy

  1997cited by this paper
• Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.

  1997cited by this paper
• A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

  1996cited by this paper
• Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

  1996cited by this paper
• Deep-vein thrombosis.

  1994cited by this paper

• Fixed dose versus 3-day loading dose warfarin initiation in atrial fibrillation: effects on INR stabilization and time in the therapeutic range.

  2026cites this paper
• Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial

  2022cites this paper
• Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review

  2022cites this paper
• Outpatient versus inpatient treatment for acute pulmonary embolism.

  2022cites this paper
• Nursing Care of Deep Vein Thrombosis

  2022cites this paper
• The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial

  2022cites this paper
• Evaluation of an Initiation Regimen of Warfarin for International Normalized Ratio Target 2.0 to 3.0

  2021cites this paper
• Genotype-Guided Dosing of Warfarin in Chinese Adults

  2020cites this paper
• Upper extremity deep vein thrombosis (UEDVT); Does end stage renal dis-ease (ESRD) triggers UEDVT?

  2020cites this paper
• Comparison of 10-mg and 5-mg warfarin initiation nomograms in a South Indian population - An open label trial.

  2019cites this paper
• Direct‐acting oral anticoagulants: a bridge to nowhere

  2019cites this paper
• Outpatient Oral Anticoagulant Therapy

  2019cites this paper
• Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study

  2019cites this paper
• Outpatient versus inpatient treatment for acute pulmonary embolism.

  2019influential citation
• [Who should supervise anticoagulant treatment and how?]

  2019cites this paper
• 2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants

  2019cites this paper
• Overview of Anticoagulation Agents

  2018cites this paper
• Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

  2018cites this paper
• Antagonistes de la vitamine K : utilisation pratique

  2018cites this paper
• The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

  2018cites this paper
• Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study

  2018cites this paper
• Genotype-guided warfarin therapy: current status.

  2018cites this paper
• Chapter 34 – Cardiovascular Drugs and Hemostasis

  2018cites this paper
• A Review of Warfarin Dosing and Monitoring

  2018cites this paper
• Optimizing quality care for the oral vitamin K antagonists (VKAs).

  2018cites this paper
• Accuracy of a Warfarin Maintenance Dose Predictor after Completion of the 10mg Initiation Nomogram

  2018cites this paper
• High-Risk Emergency Medicine

  2017cites this paper
• Impact of thrombophilia screening on venous thromboembolism management practices.

  2017cites this paper
• Early ambulation versus immobilization in the management of patients with distal deep venous thrombosis

  2017cites this paper
• Genetic-based dosing in orthopaedic patients beginning warfarin therapy Running Title: Genetic-Based Warfarin Dose Refinement

  2017cites this paper
• Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery

  2017cites this paper
• Deep Venous Thrombosis of the Upper and Lower Extremity.

  2017cites this paper
• Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism.

  2016cites this paper
• Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions

  2016cites this paper
• Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism

  2016cites this paper
• Warfarin initiation nomograms for venous thromboembolism.

  2016cites this paper
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation

  2015cites this paper
• Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials

  2015cites this paper
• Oral anticoagulation: a critique of recent advances and controversies.

  2015cites this paper
• Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre

  2015cites this paper
• Anticoagulation and Non-urgent Commercial Air Travel: A Review of the Literature.

  2015cites this paper
• THROMBOPHILIA IN PREGNANCY – CURRENT ISSUE OF MODERN PERINATOLOGY

  2015cites this paper
• Screening of patients with idiopathic venous thromboembolism for paroxysmal nocturnal hemoglobinuria clones.

  2015cites this paper
• Factors influencing warfarin response in hospitalized patients

  2015cites this paper
• Variation in warfarin prescribing and dosing in the UK: a national survey of anticoagulation clinics

  2015cites this paper
• Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.

  2015cites this paper
• Journal of Pharmaceutical and Biological Sciences

  2015cites this paper
• Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.

  2015cites this paper
• Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.

  2014cites this paper
• Treatment of venous thromboembolism.

  2014cites this paper
• Outpatient versus inpatient treatment for acute pulmonary embolism.

  2014cites this paper
• Assessment of complications of anticoagulant therapy at medical wards of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

  2014cites this paper
• Toxin-induced coagulopathy.

  2014cites this paper
• Comparison of initial loading doses of 5 mg and 10 mg for warfarin therapy

  2014cites this paper
• Warfarin Dosing and Body Mass Index

  2014cites this paper
• An update of consensus guidelines for warfarin reversal

  2014cites this paper
• Anticoagulación estratificada por riesgos

  2014cites this paper
• Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing

  2014cites this paper
• An update of consensus guidelines for warfarin reversal

  2013cites this paper
• A randomized trial of genotype-guided dosing of warfarin.

  2013cites this paper
• Warfarin initiation nomograms for venous thromboembolism.

  2013cites this paper
• An acenocoumarol dose algorithm based on a South-Eastern European population

  2013cites this paper
• Anticoagulants usuels : maniement et gestion des complications

  2013cites this paper
• Recent Advances in Antithrombotic Therapy for Stroke Prevention in Patients With Atrial Fibrillation

  2013cites this paper
• 39 – Outpatient Anticoagulant Therapy

  2013cites this paper
• Guidelines for use of anticoagulation in pregnancy.

  2013cites this paper
• “Islet equivalent” stem cells and diabetes

  2013cites this paper
• Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices.

  2013cites this paper
• A Systems Approach to Designing Effective Clinical Trials Using Simulations

  2013cites this paper
• Pharmacogenetics of Oral Anticoagulants and Antiplatelets

  2013cites this paper
• Warfarin: its highs and lows.

  2013cites this paper
• Development of a Guideline for Treatment of Deep and Superficial Venous Thrombosis in the Emergency Department

  2012cites this paper
• Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation

  2012cites this paper
• Age‐ and weight‐adjusted warfarin initiation nomogram for ischaemic stroke patients

  2012influential citation
• Management of Warfarin Therapy

  2012cites this paper
• Advances in the management of venous thromboembolism.

  2012cites this paper
• Surveillance des traitements anticoagulants : dérivés hépariniques et antivitamine K

  2012cites this paper
• Combined effect of CYP2C9 and VKORC1 polymorphisms on warfarin maintenance dose in Omani patients

  2012cites this paper
• Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin

  2012cites this paper
• A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

  2012cites this paper
• Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Baricitinib/Filgotinib

  2012cites this paper
• Pharmacologically-based mechanistic modelling in health economic evaluation

  2012cites this paper
• Prediction of warfarin dose: why, when and how?

  2012cites this paper
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Pharmacogenomics Aspect of Warfarin Therapy

  2012cites this paper
• Upper extremity deep vein thrombosis

  2012cites this paper
• Optimal loading dose of warfarin for the initiation of oral anticoagulation.

  2012cites this paper
• High doses of warfarin are more beneficial than its low doses in patients with deep vein thrombosis.

  2011influential citation
• Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation

  2011cites this paper
• Using Pharmacogenetics in Real Time to Guide Warfarin Initiation: A Clinician Update

  2011cites this paper
• Pharmacology of Vitamin K Antagonists

  2011cites this paper
• Warfarin for Refractory Chronic Cluster Headache: A Randomized Pilot Study

  2011cites this paper
• The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.

  2011cites this paper
• Dosing Options for Decreasing the Time to Achieve Therapeutic Anticoagulation When Reinitiating Warfarin: A Case Series

  2011cites this paper
• Pathology consultation on warfarin pharmacogenetic testing.

  2011cites this paper
• Optimizing Inpatient Anticoagulation: Strategies for Quality Improvement

  2011cites this paper
• Oral anticoagulation: A review of the current and emerging therapies

  2011cites this paper
• Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.

  2011cites this paper
• Optimal loading dose for the initiation of warfarin: a systematic review

  2010cites this paper